Mono-, di- and tri-methylation at Histone 3 Lysine 27 by the HMT EZH2 is known to be specifically increased in neuroblastoma [88], particularly in MYCN amplified tumours [89], and also associated with poor patient outcome [90]. Here, MYCN is linked to neuroblastoma.